Cleared Special

K071927 - MODIFICATION TO VERTEBROPLASTIC RADIOPAQUE BONE CEMENT (FDA 510(k) Clearance)

Class II Orthopedic device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K071927 · Depuy Spine, A Johnson & Johnson Company · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
132d
Days
Class 2
Risk

K071927 is an FDA 510(k) clearance for the MODIFICATION TO VERTEBROPLASTIC RADIOPAQUE BONE CEMENT. Classified as Cement, Bone, Vertebroplasty (product code NDN), Class II - Special Controls.

Submitted by Depuy Spine, A Johnson & Johnson Company (Raynham, US). The FDA issued a Cleared decision on November 21, 2007 after a review of 132 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3027 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Depuy Spine, A Johnson & Johnson Company devices

Submission Details

510(k) Number K071927 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2007
Decision Date November 21, 2007
Days to Decision 132 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 122d · This submission: 132d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NDN Cement, Bone, Vertebroplasty
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3027
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - NDN Cement, Bone, Vertebroplasty

All 107
Devices cleared under the same product code (NDN) and FDA review panel - the closest regulatory comparables to K071927.
XeliteMed SuperM-Fix Spinal Bone Cement
K251896 · Xelite Biomed , Ltd. · Jan 2026
VCFix Spinal System
K250637 · Amber Implants · May 2025
XeliteMed VertehighFix High Viscosity Spinal Bone Cement System
K243537 · Xelite Biomed , Ltd. · Apr 2025
XeliteMed VertehighFix High Viscosity Spinal Bone Cement
K241775 · Xelite Biomed , Ltd. · Sep 2024
Balloon Inflation System
K232842 · Ningbo Hicren Biotechnology Co., Ltd. · Feb 2024
V-STRUT® Vertebral Implant
K240084 · Hyprevention · Feb 2024